Evidence map›Paper›PMID 31807194›Full record

ArticleOncology letters2019

Gene expression of

Ewa Wrona, Justyna Jakubowska, Bartłomiej Pawlik, Agata Pastorczak, Joanna Madzio, Monika Lejman, Łukasz Sędek, Jerzy Kowalczyk, Tomasz Szczepański, Wojciech Młynarski

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ewa WronaDepartment of Chemotherapy, Medical University of Lodz, Lodz 91-738, Poland.
Justyna JakubowskaDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz 91-738, Poland.
Bartłomiej PawlikDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz 91-738, Poland.
Agata PastorczakDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz 91-738, Poland.
Joanna MadzioDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz 91-738, Poland.
Monika LejmanDepartment of Pediatric Hematology and Oncology, Medical University of Lublin, Lublin 20-093, Poland.
Łukasz SędekDepartment of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Katowice 40-752, Poland.
Jerzy KowalczykDepartment of Pediatric Hematology and Oncology, Medical University of Lublin, Lublin 20-093, Poland.
Tomasz SzczepańskiDepartment of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Katowice 40-752, Poland.
Wojciech MłynarskiDepartment of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz 91-738, Poland.
Medical University of Lodz · PLMedical University of Lublin · PLMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to L-asparaginase (L-asp) is a major contributor to poor treatment outcomes of several subtypes of childhood B cell precursor acute lymphoblastic leukemia (BCP-ALL). Asparagine synthetase (

Indexed as

asparagine synthetasecathepsin Bchildhood B cell precursor acute lymphoblastic leukemiaL-asparaginase resistancelegumainpaired box 5 deletionrelapse-free survival

Identifiers

PMID31807194
PMCPMC6876287
OpenAlexW2986405012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.